Alpha-Linolenic Acid and Docosahexaenoic Acid: study protocols
4 study groups took Alpha-Linolenic Acid together with Docosahexaenoic Acid. These are the doses the studies gave. They are not a recommendation.
Fewer than 5 study groups in one unit match, too few to draw the chart.
Commonly used together
2 of 4 study groups took Alpha-Linolenic Acid and Docosahexaenoic Acid with something else, but nothing that 3 or more different studies gave.
4 study groups
| Study | ||||
|---|---|---|---|---|
| n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes 2011 · EPA-DHA plus ALA · Adults aged 60–80 with diabetes and a previous myocardial infarction | 2 g | — | 1217 days | 245 |
| The effect of a 1-year multiple micronutrient or n-3 fatty acid fortified food intervention on morbidity in Indian school children 2012 · High micronutrients + high n-3 fatty acids · Children aged 6–10 years in India | 900 mg | 100 mg | 1 year | — |
| The effect of a 1-year multiple micronutrient or n-3 fatty acid fortified food intervention on morbidity in Indian school children 2012 · Low micronutrients + high n-3 fatty acids · Children aged 6–10 years in India | 900 mg | 100 mg | 1 year | — |
| Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial 2014 · eicosapentaenoic acid-docosahexaenoic acid plus α-linolenic acid group · Patients aged 60–80 years with a history of myocardial infarction; 81% were men. | 1.99 g | 159 mg | 1200 days | — |